{name}
{subtitle}
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
city
~73 mi. (Przemyśl, Poland, +93 more cities)
facility
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1053)
condition
Bladder Carcinoma, +1 more condition
drug
cisplatin, +4 more drugs
drug type
chemotherapy, +3 more types
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~73 mi. (Lublin, Poland, +199 more cities)
facility
Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie ( Site 0620)
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~73 mi. (Lublin, Poland, +201 more cities)
facility
Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie /ID# 221667
drug
azacitidine, +1 more drug
Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)
city
~73 mi. (Przemyśl, Poland, +34 more cities)
facility
Wojewódzki Szpital im. Św. Ojca Pio w Przemyślu ( Site 0249)
drug
lenvatinib, +2 more drugs
drug type
immunotherapy, +1 more type
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
city
~75 mi. (Brzozów, Poland, +72 more cities)
facility
Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. Ks. B. Markiewicza
biomarker
del(11)(q10), +27 more biomarkers
condition
Primary Myelofibrosis, +1 more condition
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
city
~86 mi. (Tarnów, Poland, +163 more cities)
facility
Szpital Wojewodzki ( Site 1062)
drug
cystectomy, +2 more drugs
drug type
chemotherapy, +3 more types